Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation A modelling analysis from the Euro Heart Survey

Ron Pisters, Robby Nieuwlaat, Deirdre A. Lane, Harry J. G. M. Crijns, Gregory Y. H. Lip

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)328-336
JournalThrombosis and Haemostasis
Volume109
Issue number2
DOIs
Publication statusPublished - Feb 2013

Keywords

  • Atrial fibrillation
  • oral anticoagulation
  • stroke prevention

Cite this